ATIBUCLIMAB
UNII 23IQ3PO968

Substance Identification & Data

This profile provides standardized clinical and technical data for Atibuclimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 23IQ3PO968.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2417175-94-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
23IQ3PO968
CAS Registry Number
2417175-94-9
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ATIBUCLIMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
11865
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Atibuclimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ATIBUCLIMAB

Common Names & Synonyms

ATIBUCLIMAB [INN]
ATIBUCLIMAB [WHO-DD]
IC14, (RECOMBINANT CHIMERIC MAB AGAINST HUMAN CD14)
IMMUNOGLOBULIN G4, ANTI-(HUMAN CD14 ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL IC14 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL IC14 .KAPPA.-CHAIN, DIMER

Technical Codes

IC14
IC-14